DB17643ExperimentalProtein Based Therapies
AEM-28-14 is an analog of AEM-28, an apolipoprotein E mimetic peptide, with a 400 percent greater cholesterol-lowering efficacy and a several-fold increase in drug tolerability. It is being investigated for... It is being investigated for lipid disorders such as homozygous familial hypercholesterolemia.
- Code names
- AEM-28-14
What you can answer from here — as of April 02, 2025
Which companies are running trials of AEM-28-14, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account